| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2002
|
3.93
|
|
2
|
The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
|
Int J Radiat Oncol Biol Phys
|
2002
|
2.09
|
|
3
|
Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.96
|
|
4
|
Limited-field radiation therapy in the management of early-stage breast cancer.
|
J Natl Cancer Inst
|
2003
|
1.89
|
|
5
|
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.
|
Radiother Oncol
|
2010
|
1.87
|
|
6
|
Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.75
|
|
7
|
Cone-beam-CT guided radiation therapy: A model for on-line application.
|
Radiother Oncol
|
2005
|
1.66
|
|
8
|
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.65
|
|
9
|
Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.61
|
|
10
|
Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.60
|
|
11
|
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.58
|
|
12
|
An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up.
|
Cancer
|
2002
|
1.50
|
|
13
|
Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.41
|
|
14
|
Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.39
|
|
15
|
Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.33
|
|
16
|
Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.30
|
|
17
|
Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.23
|
|
18
|
Clinical applications of volumetric modulated arc therapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.23
|
|
19
|
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.21
|
|
20
|
Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.17
|
|
21
|
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.17
|
|
22
|
Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
|
Int J Radiat Oncol Biol Phys
|
2009
|
1.14
|
|
23
|
Computed tomography guided management of interfractional patient variation.
|
Semin Radiat Oncol
|
2005
|
1.12
|
|
24
|
Geometric and dosimetric evaluations of an online image-guidance strategy for 3D-CRT of prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.11
|
|
25
|
Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
|
Int J Radiat Oncol Biol Phys
|
2003
|
1.11
|
|
26
|
Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer.
|
J Urol
|
2005
|
1.06
|
|
27
|
Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
|
Cancer
|
2003
|
1.06
|
|
28
|
Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy.
|
J Urol
|
2002
|
1.02
|
|
29
|
Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
|
Am J Surg
|
2004
|
1.02
|
|
30
|
High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data.
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.00
|
|
31
|
Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.98
|
|
32
|
A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.96
|
|
33
|
Adaptive radiation therapy for prostate cancer.
|
Semin Radiat Oncol
|
2010
|
0.95
|
|
34
|
The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer.
|
Cancer Radiother
|
2004
|
0.94
|
|
35
|
The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.94
|
|
36
|
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.92
|
|
37
|
Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
|
Cancer
|
2004
|
0.90
|
|
38
|
Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.90
|
|
39
|
Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.88
|
|
40
|
Comparison of planned versus actual dose delivered for external beam accelerated partial breast irradiation using cone-beam CT and deformable registration.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.85
|
|
41
|
The emerging role of brachytherapy in the management of patients with breast cancer.
|
Semin Radiat Oncol
|
2002
|
0.85
|
|
42
|
Image guidance in external beam accelerated partial breast irradiation: comparison of surrogates for the lumpectomy cavity.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.85
|
|
43
|
Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.83
|
|
44
|
Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy.
|
Cancer
|
2010
|
0.83
|
|
45
|
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.83
|
|
46
|
Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?
|
Strahlenther Onkol
|
2006
|
0.83
|
|
47
|
Treatment of linear mandibular fractures using a single 2.0-mm AO locking reconstruction plate: is a second plate necessary?
|
J Oral Maxillofac Surg
|
2009
|
0.83
|
|
48
|
Differences in disease presentation, treatment outcomes, and toxicities in African American patients treated with radiation therapy for prostate cancer.
|
Am J Clin Oncol
|
2012
|
0.81
|
|
49
|
Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.81
|
|
50
|
A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
|
J Urol
|
2005
|
0.80
|
|
51
|
Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavir.
|
J Int Assoc Physicians AIDS Care (Chic)
|
2008
|
0.79
|
|
52
|
Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.79
|
|
53
|
Lateral antrotomy as a surgical approach for maxillary sinus: a modified technique with free bone flap repositioning and fixation with a titanium plate.
|
J Oral Maxillofac Surg
|
2009
|
0.78
|
|
54
|
High dose rate brachytherapy in the treatment of prostate cancer.
|
World J Urol
|
2003
|
0.78
|
|
55
|
The role of high-dose rate brachytherapy in locally advanced prostate cancer.
|
Semin Radiat Oncol
|
2003
|
0.76
|
|
56
|
The use of intensity modulated radiation therapy in the treatment of breast cancer: evolving definition, misdirected criticism, and untoward effects.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.75
|
|
57
|
Longitudinal assessment of quality of life and audiometric test outcomes in vestibular schwannoma patients treated with gamma knife surgery.
|
Otol Neurotol
|
2011
|
0.75
|
|
58
|
Sulfur toxicity and media capacity for H2S removal in biofilters packed with a natural or a commercial granular medium.
|
J Air Waste Manag Assoc
|
2005
|
0.75
|
|
59
|
Complex orbito-fronto-temporal reconstruction using computer-designed PEEK implant.
|
J Craniofac Surg
|
2007
|
0.75
|
|
60
|
A nasopalatine duct cyst in a 7-year-old child.
|
Pediatr Dent
|
2009
|
0.75
|
|
61
|
Radiation dose for prostate cancer: is more better?
|
Nat Clin Pract Oncol
|
2006
|
0.75
|